Stay updated on Seladelpar in Primary Biliary Cholangitis Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in Primary Biliary Cholangitis Clinical Trial page.

Latest updates to the Seladelpar in Primary Biliary Cholangitis Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.3.4 was added and revision: v3.3.3 was removed, indicating an administrative page update, with no impact on study details, eligibility criteria, outcomes, or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA centralized Locations section is added and populated with study sites across the United States and Canada. The page version is updated to v3.3.3 and the HHS Vulnerability Disclosure link is removed.SummaryDifference1%

- Check57 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed and may not be about the study, and the revision has been updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedThe government funding status notice about potential delays and NIH operating status has been removed from the page.SummaryDifference0.3%

- Check78 days agoChange DetectedNo significant changes detected in the Study Details page; core content and study parameters appear unchanged.SummaryDifference0.3%

- Check107 days agoChange DetectedAdded a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0 revision.SummaryDifference2%

Stay in the know with updates to Seladelpar in Primary Biliary Cholangitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in Primary Biliary Cholangitis Clinical Trial page.